Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Adicionar filtros








Intervalo de ano
1.
The Korean Journal of Internal Medicine ; : 693-695, 2018.
Artigo em Inglês | WPRIM | ID: wpr-716078

RESUMO

No abstract available.


Assuntos
Humanos , Neoplasias Colorretais
2.
Brain Tumor Research and Treatment ; : 138-141, 2016.
Artigo em Inglês | WPRIM | ID: wpr-27924

RESUMO

Uterine adenosarcoma (AS) are rare tumors and have more favorable outcomes than the aggressive uterine carcinosarcomas. Uterine adenosarcoma with sarcomatous overgrowth (ASSO) is a variant form of AS and exhibits aggressive growth of tumor and the prognosis is relatively poor compared with typical AS. Usually patterns of metastasis have been known to behave like endometrial carcinoma and spread through the lymphatics. Brain metastasis from uterine AS is extremely rare. Herein, we report a case of successfully surgically removed solitary brain metastasis without any extracranial recurrence from uterine ASSO after 4 years of primary treatment.


Assuntos
Feminino , Adenossarcoma , Encéfalo , Carcinossarcoma , Neoplasias do Endométrio , Metástase Neoplásica , Prognóstico , Recidiva
3.
Korean Circulation Journal ; : 497-499, 2013.
Artigo em Inglês | WPRIM | ID: wpr-167933

RESUMO

Combination treatment of antiplatelet drugs containing aspirin and clopidogrel reduces systemic ischemic events after percutaneous coronary intervention (PCI) in high risk patients. However, this combination treatment of antiplatelet drugs is associated with increased risk of nonfatal and fatal bleeding. Diffuse alveolar hemorrhage after PCI is a rare complication that has been mostly reported in association with glycoprotein IIb/IIIa inhibitors. We report the case of a 62-year-old man who presented with ST elevation myocardial infarction and suffered a diffuse alveolar hemorrhage after clopidogrel use following primary PCI.


Assuntos
Humanos , Aspirina , Glicoproteínas , Hemoptise , Hemorragia , Infarto do Miocárdio , Intervenção Coronária Percutânea , Inibidores da Agregação Plaquetária , Ticlopidina
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA